Parenteral Drugs Market - Global Outlook and Forecast 2022-2028
Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion. They are infused when administered intravenously (IV), or injected when administered intramuscularly (IM), or subcutaneously into the human body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml that is terminally sterilized by heat. Small volume parenteral (SVP) is a 'catch-all' for all non-LVP parenterals products except biologicals.
This report contains market size and forecasts of Parenteral Drugs in global, including the following market information:
Global Parenteral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Parenteral Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Parenteral Drugs companies in 2021 (%)
The global Parenteral Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
LVP Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Parenteral Drugs include Ostuka Pharmaceutical, Teva Pharmaceutical Industries, Kelun Pharma, Cook Pharmica, Patheon, BAG Healthcare, Beximco Pharma, Baxter Healthcare Corporation and B. Braun, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Parenteral Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parenteral Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, by Type, 2021 (%)
Global Parenteral Drugs Market Segment Percentages, by Application, 2021 (%)
Global Parenteral Drugs Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Parenteral Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Parenteral Drugs revenues share in global market, 2021 (%)
Key companies Parenteral Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Parenteral Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Parenteral Drugs in global, including the following market information:
Global Parenteral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Parenteral Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Parenteral Drugs companies in 2021 (%)
The global Parenteral Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
LVP Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Parenteral Drugs include Ostuka Pharmaceutical, Teva Pharmaceutical Industries, Kelun Pharma, Cook Pharmica, Patheon, BAG Healthcare, Beximco Pharma, Baxter Healthcare Corporation and B. Braun, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Parenteral Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parenteral Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, by Type, 2021 (%)
- LVP Drug
- SVP Drug
Global Parenteral Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Medical Centers
- Others
Global Parenteral Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Parenteral Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Parenteral Drugs revenues share in global market, 2021 (%)
Key companies Parenteral Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Parenteral Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Ostuka Pharmaceutical
- Teva Pharmaceutical Industries
- Kelun Pharma
- Cook Pharmica
- Patheon
- BAG Healthcare
- Beximco Pharma
- Baxter Healthcare Corporation
- B. Braun
- Fresenius
- Albert David
- BML Parenteral Drugs
- Pfizer (Hospira)
- Pisa
- Ozon Pharmaceuticals Ltd
- Aspen Holdings
- PSI Ltd
- Wintac Limited
- AXA Parenterals Ltd
- Acebright
- Southwest Pharmaceutical
- Abbott
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Parenteral Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parenteral Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PARENTERAL DRUGS OVERALL MARKET SIZE
2.1 Global Parenteral Drugs Market Size: 2021 VS 2028
2.2 Global Parenteral Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Parenteral Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Parenteral Drugs Players in Global Market
3.2 Top Global Parenteral Drugs Companies Ranked by Revenue
3.3 Global Parenteral Drugs Revenue by Companies
3.4 Global Parenteral Drugs Sales by Companies
3.5 Global Parenteral Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Parenteral Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Parenteral Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Parenteral Drugs Players in Global Market
3.8.1 List of Global Tier 1 Parenteral Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Parenteral Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Parenteral Drugs Market Size Markets, 2021 & 2028
4.1.2 LVP Drug
4.1.3 SVP Drug
4.2 By Type - Global Parenteral Drugs Revenue & Forecasts
4.2.1 By Type - Global Parenteral Drugs Revenue, 2017-2022
4.2.2 By Type - Global Parenteral Drugs Revenue, 2023-2028
4.2.3 By Type - Global Parenteral Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Parenteral Drugs Sales & Forecasts
4.3.1 By Type - Global Parenteral Drugs Sales, 2017-2022
4.3.2 By Type - Global Parenteral Drugs Sales, 2023-2028
4.3.3 By Type - Global Parenteral Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Parenteral Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Parenteral Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Medical Centers
5.1.4 Others
5.2 By Application - Global Parenteral Drugs Revenue & Forecasts
5.2.1 By Application - Global Parenteral Drugs Revenue, 2017-2022
5.2.2 By Application - Global Parenteral Drugs Revenue, 2023-2028
5.2.3 By Application - Global Parenteral Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Parenteral Drugs Sales & Forecasts
5.3.1 By Application - Global Parenteral Drugs Sales, 2017-2022
5.3.2 By Application - Global Parenteral Drugs Sales, 2023-2028
5.3.3 By Application - Global Parenteral Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Parenteral Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Parenteral Drugs Market Size, 2021 & 2028
6.2 By Region - Global Parenteral Drugs Revenue & Forecasts
6.2.1 By Region - Global Parenteral Drugs Revenue, 2017-2022
6.2.2 By Region - Global Parenteral Drugs Revenue, 2023-2028
6.2.3 By Region - Global Parenteral Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Parenteral Drugs Sales & Forecasts
6.3.1 By Region - Global Parenteral Drugs Sales, 2017-2022
6.3.2 By Region - Global Parenteral Drugs Sales, 2023-2028
6.3.3 By Region - Global Parenteral Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Parenteral Drugs Revenue, 2017-2028
6.4.2 By Country - North America Parenteral Drugs Sales, 2017-2028
6.4.3 US Parenteral Drugs Market Size, 2017-2028
6.4.4 Canada Parenteral Drugs Market Size, 2017-2028
6.4.5 Mexico Parenteral Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Parenteral Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Parenteral Drugs Sales, 2017-2028
6.5.3 Germany Parenteral Drugs Market Size, 2017-2028
6.5.4 France Parenteral Drugs Market Size, 2017-2028
6.5.5 U.K. Parenteral Drugs Market Size, 2017-2028
6.5.6 Italy Parenteral Drugs Market Size, 2017-2028
6.5.7 Russia Parenteral Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Parenteral Drugs Market Size, 2017-2028
6.5.9 Benelux Parenteral Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Parenteral Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Parenteral Drugs Sales, 2017-2028
6.6.3 China Parenteral Drugs Market Size, 2017-2028
6.6.4 Japan Parenteral Drugs Market Size, 2017-2028
6.6.5 South Korea Parenteral Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Parenteral Drugs Market Size, 2017-2028
6.6.7 India Parenteral Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Parenteral Drugs Revenue, 2017-2028
6.7.2 By Country - South America Parenteral Drugs Sales, 2017-2028
6.7.3 Brazil Parenteral Drugs Market Size, 2017-2028
6.7.4 Argentina Parenteral Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Parenteral Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Parenteral Drugs Sales, 2017-2028
6.8.3 Turkey Parenteral Drugs Market Size, 2017-2028
6.8.4 Israel Parenteral Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Parenteral Drugs Market Size, 2017-2028
6.8.6 UAE Parenteral Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Ostuka Pharmaceutical
7.1.1 Ostuka Pharmaceutical Corporate Summary
7.1.2 Ostuka Pharmaceutical Business Overview
7.1.3 Ostuka Pharmaceutical Parenteral Drugs Major Product Offerings
7.1.4 Ostuka Pharmaceutical Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Ostuka Pharmaceutical Key News
7.2 Teva Pharmaceutical Industries
7.2.1 Teva Pharmaceutical Industries Corporate Summary
7.2.2 Teva Pharmaceutical Industries Business Overview
7.2.3 Teva Pharmaceutical Industries Parenteral Drugs Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Teva Pharmaceutical Industries Key News
7.3 Kelun Pharma
7.3.1 Kelun Pharma Corporate Summary
7.3.2 Kelun Pharma Business Overview
7.3.3 Kelun Pharma Parenteral Drugs Major Product Offerings
7.3.4 Kelun Pharma Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Kelun Pharma Key News
7.4 Cook Pharmica
7.4.1 Cook Pharmica Corporate Summary
7.4.2 Cook Pharmica Business Overview
7.4.3 Cook Pharmica Parenteral Drugs Major Product Offerings
7.4.4 Cook Pharmica Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Cook Pharmica Key News
7.5 Patheon
7.5.1 Patheon Corporate Summary
7.5.2 Patheon Business Overview
7.5.3 Patheon Parenteral Drugs Major Product Offerings
7.5.4 Patheon Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Patheon Key News
7.6 BAG Healthcare
7.6.1 BAG Healthcare Corporate Summary
7.6.2 BAG Healthcare Business Overview
7.6.3 BAG Healthcare Parenteral Drugs Major Product Offerings
7.6.4 BAG Healthcare Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.6.5 BAG Healthcare Key News
7.7 Beximco Pharma
7.7.1 Beximco Pharma Corporate Summary
7.7.2 Beximco Pharma Business Overview
7.7.3 Beximco Pharma Parenteral Drugs Major Product Offerings
7.7.4 Beximco Pharma Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Beximco Pharma Key News
7.8 Baxter Healthcare Corporation
7.8.1 Baxter Healthcare Corporation Corporate Summary
7.8.2 Baxter Healthcare Corporation Business Overview
7.8.3 Baxter Healthcare Corporation Parenteral Drugs Major Product Offerings
7.8.4 Baxter Healthcare Corporation Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Baxter Healthcare Corporation Key News
7.9 B. Braun
7.9.1 B. Braun Corporate Summary
7.9.2 B. Braun Business Overview
7.9.3 B. Braun Parenteral Drugs Major Product Offerings
7.9.4 B. Braun Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.9.5 B. Braun Key News
7.10 Fresenius
7.10.1 Fresenius Corporate Summary
7.10.2 Fresenius Business Overview
7.10.3 Fresenius Parenteral Drugs Major Product Offerings
7.10.4 Fresenius Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Fresenius Key News
7.11 Albert David
7.11.1 Albert David Corporate Summary
7.11.2 Albert David Parenteral Drugs Business Overview
7.11.3 Albert David Parenteral Drugs Major Product Offerings
7.11.4 Albert David Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Albert David Key News
7.12 BML Parenteral Drugs
7.12.1 BML Parenteral Drugs Corporate Summary
7.12.2 BML Parenteral Drugs Parenteral Drugs Business Overview
7.12.3 BML Parenteral Drugs Parenteral Drugs Major Product Offerings
7.12.4 BML Parenteral Drugs Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.12.5 BML Parenteral Drugs Key News
7.13 Pfizer (Hospira)
7.13.1 Pfizer (Hospira) Corporate Summary
7.13.2 Pfizer (Hospira) Parenteral Drugs Business Overview
7.13.3 Pfizer (Hospira) Parenteral Drugs Major Product Offerings
7.13.4 Pfizer (Hospira) Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Pfizer (Hospira) Key News
7.14 Pisa
7.14.1 Pisa Corporate Summary
7.14.2 Pisa Business Overview
7.14.3 Pisa Parenteral Drugs Major Product Offerings
7.14.4 Pisa Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Pisa Key News
7.15 Ozon Pharmaceuticals Ltd
7.15.1 Ozon Pharmaceuticals Ltd Corporate Summary
7.15.2 Ozon Pharmaceuticals Ltd Business Overview
7.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Major Product Offerings
7.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Ozon Pharmaceuticals Ltd Key News
7.16 Aspen Holdings
7.16.1 Aspen Holdings Corporate Summary
7.16.2 Aspen Holdings Business Overview
7.16.3 Aspen Holdings Parenteral Drugs Major Product Offerings
7.16.4 Aspen Holdings Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Aspen Holdings Key News
7.17 PSI Ltd
7.17.1 PSI Ltd Corporate Summary
7.17.2 PSI Ltd Business Overview
7.17.3 PSI Ltd Parenteral Drugs Major Product Offerings
7.17.4 PSI Ltd Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.17.5 PSI Ltd Key News
7.18 Wintac Limited
7.18.1 Wintac Limited Corporate Summary
7.18.2 Wintac Limited Business Overview
7.18.3 Wintac Limited Parenteral Drugs Major Product Offerings
7.18.4 Wintac Limited Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Wintac Limited Key News
7.19 AXA Parenterals Ltd
7.19.1 AXA Parenterals Ltd Corporate Summary
7.19.2 AXA Parenterals Ltd Business Overview
7.19.3 AXA Parenterals Ltd Parenteral Drugs Major Product Offerings
7.19.4 AXA Parenterals Ltd Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.19.5 AXA Parenterals Ltd Key News
7.20 Acebright
7.20.1 Acebright Corporate Summary
7.20.2 Acebright Business Overview
7.20.3 Acebright Parenteral Drugs Major Product Offerings
7.20.4 Acebright Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.20.5 Acebright Key News
7.21 Southwest Pharmaceutical
7.21.1 Southwest Pharmaceutical Corporate Summary
7.21.2 Southwest Pharmaceutical Business Overview
7.21.3 Southwest Pharmaceutical Parenteral Drugs Major Product Offerings
7.21.4 Southwest Pharmaceutical Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.21.5 Southwest Pharmaceutical Key News
7.22 Abbott
7.22.1 Abbott Corporate Summary
7.22.2 Abbott Business Overview
7.22.3 Abbott Parenteral Drugs Major Product Offerings
7.22.4 Abbott Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.22.5 Abbott Key News
8 GLOBAL PARENTERAL DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Parenteral Drugs Production Capacity, 2017-2028
8.2 Parenteral Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Parenteral Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PARENTERAL DRUGS SUPPLY CHAIN ANALYSIS
10.1 Parenteral Drugs Industry Value Chain
10.2 Parenteral Drugs Upstream Market
10.3 Parenteral Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Parenteral Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Parenteral Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parenteral Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PARENTERAL DRUGS OVERALL MARKET SIZE
2.1 Global Parenteral Drugs Market Size: 2021 VS 2028
2.2 Global Parenteral Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Parenteral Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Parenteral Drugs Players in Global Market
3.2 Top Global Parenteral Drugs Companies Ranked by Revenue
3.3 Global Parenteral Drugs Revenue by Companies
3.4 Global Parenteral Drugs Sales by Companies
3.5 Global Parenteral Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Parenteral Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Parenteral Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Parenteral Drugs Players in Global Market
3.8.1 List of Global Tier 1 Parenteral Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Parenteral Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Parenteral Drugs Market Size Markets, 2021 & 2028
4.1.2 LVP Drug
4.1.3 SVP Drug
4.2 By Type - Global Parenteral Drugs Revenue & Forecasts
4.2.1 By Type - Global Parenteral Drugs Revenue, 2017-2022
4.2.2 By Type - Global Parenteral Drugs Revenue, 2023-2028
4.2.3 By Type - Global Parenteral Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Parenteral Drugs Sales & Forecasts
4.3.1 By Type - Global Parenteral Drugs Sales, 2017-2022
4.3.2 By Type - Global Parenteral Drugs Sales, 2023-2028
4.3.3 By Type - Global Parenteral Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Parenteral Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Parenteral Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Medical Centers
5.1.4 Others
5.2 By Application - Global Parenteral Drugs Revenue & Forecasts
5.2.1 By Application - Global Parenteral Drugs Revenue, 2017-2022
5.2.2 By Application - Global Parenteral Drugs Revenue, 2023-2028
5.2.3 By Application - Global Parenteral Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Parenteral Drugs Sales & Forecasts
5.3.1 By Application - Global Parenteral Drugs Sales, 2017-2022
5.3.2 By Application - Global Parenteral Drugs Sales, 2023-2028
5.3.3 By Application - Global Parenteral Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Parenteral Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Parenteral Drugs Market Size, 2021 & 2028
6.2 By Region - Global Parenteral Drugs Revenue & Forecasts
6.2.1 By Region - Global Parenteral Drugs Revenue, 2017-2022
6.2.2 By Region - Global Parenteral Drugs Revenue, 2023-2028
6.2.3 By Region - Global Parenteral Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Parenteral Drugs Sales & Forecasts
6.3.1 By Region - Global Parenteral Drugs Sales, 2017-2022
6.3.2 By Region - Global Parenteral Drugs Sales, 2023-2028
6.3.3 By Region - Global Parenteral Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Parenteral Drugs Revenue, 2017-2028
6.4.2 By Country - North America Parenteral Drugs Sales, 2017-2028
6.4.3 US Parenteral Drugs Market Size, 2017-2028
6.4.4 Canada Parenteral Drugs Market Size, 2017-2028
6.4.5 Mexico Parenteral Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Parenteral Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Parenteral Drugs Sales, 2017-2028
6.5.3 Germany Parenteral Drugs Market Size, 2017-2028
6.5.4 France Parenteral Drugs Market Size, 2017-2028
6.5.5 U.K. Parenteral Drugs Market Size, 2017-2028
6.5.6 Italy Parenteral Drugs Market Size, 2017-2028
6.5.7 Russia Parenteral Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Parenteral Drugs Market Size, 2017-2028
6.5.9 Benelux Parenteral Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Parenteral Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Parenteral Drugs Sales, 2017-2028
6.6.3 China Parenteral Drugs Market Size, 2017-2028
6.6.4 Japan Parenteral Drugs Market Size, 2017-2028
6.6.5 South Korea Parenteral Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Parenteral Drugs Market Size, 2017-2028
6.6.7 India Parenteral Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Parenteral Drugs Revenue, 2017-2028
6.7.2 By Country - South America Parenteral Drugs Sales, 2017-2028
6.7.3 Brazil Parenteral Drugs Market Size, 2017-2028
6.7.4 Argentina Parenteral Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Parenteral Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Parenteral Drugs Sales, 2017-2028
6.8.3 Turkey Parenteral Drugs Market Size, 2017-2028
6.8.4 Israel Parenteral Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Parenteral Drugs Market Size, 2017-2028
6.8.6 UAE Parenteral Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Ostuka Pharmaceutical
7.1.1 Ostuka Pharmaceutical Corporate Summary
7.1.2 Ostuka Pharmaceutical Business Overview
7.1.3 Ostuka Pharmaceutical Parenteral Drugs Major Product Offerings
7.1.4 Ostuka Pharmaceutical Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Ostuka Pharmaceutical Key News
7.2 Teva Pharmaceutical Industries
7.2.1 Teva Pharmaceutical Industries Corporate Summary
7.2.2 Teva Pharmaceutical Industries Business Overview
7.2.3 Teva Pharmaceutical Industries Parenteral Drugs Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Teva Pharmaceutical Industries Key News
7.3 Kelun Pharma
7.3.1 Kelun Pharma Corporate Summary
7.3.2 Kelun Pharma Business Overview
7.3.3 Kelun Pharma Parenteral Drugs Major Product Offerings
7.3.4 Kelun Pharma Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Kelun Pharma Key News
7.4 Cook Pharmica
7.4.1 Cook Pharmica Corporate Summary
7.4.2 Cook Pharmica Business Overview
7.4.3 Cook Pharmica Parenteral Drugs Major Product Offerings
7.4.4 Cook Pharmica Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Cook Pharmica Key News
7.5 Patheon
7.5.1 Patheon Corporate Summary
7.5.2 Patheon Business Overview
7.5.3 Patheon Parenteral Drugs Major Product Offerings
7.5.4 Patheon Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Patheon Key News
7.6 BAG Healthcare
7.6.1 BAG Healthcare Corporate Summary
7.6.2 BAG Healthcare Business Overview
7.6.3 BAG Healthcare Parenteral Drugs Major Product Offerings
7.6.4 BAG Healthcare Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.6.5 BAG Healthcare Key News
7.7 Beximco Pharma
7.7.1 Beximco Pharma Corporate Summary
7.7.2 Beximco Pharma Business Overview
7.7.3 Beximco Pharma Parenteral Drugs Major Product Offerings
7.7.4 Beximco Pharma Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Beximco Pharma Key News
7.8 Baxter Healthcare Corporation
7.8.1 Baxter Healthcare Corporation Corporate Summary
7.8.2 Baxter Healthcare Corporation Business Overview
7.8.3 Baxter Healthcare Corporation Parenteral Drugs Major Product Offerings
7.8.4 Baxter Healthcare Corporation Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Baxter Healthcare Corporation Key News
7.9 B. Braun
7.9.1 B. Braun Corporate Summary
7.9.2 B. Braun Business Overview
7.9.3 B. Braun Parenteral Drugs Major Product Offerings
7.9.4 B. Braun Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.9.5 B. Braun Key News
7.10 Fresenius
7.10.1 Fresenius Corporate Summary
7.10.2 Fresenius Business Overview
7.10.3 Fresenius Parenteral Drugs Major Product Offerings
7.10.4 Fresenius Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Fresenius Key News
7.11 Albert David
7.11.1 Albert David Corporate Summary
7.11.2 Albert David Parenteral Drugs Business Overview
7.11.3 Albert David Parenteral Drugs Major Product Offerings
7.11.4 Albert David Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Albert David Key News
7.12 BML Parenteral Drugs
7.12.1 BML Parenteral Drugs Corporate Summary
7.12.2 BML Parenteral Drugs Parenteral Drugs Business Overview
7.12.3 BML Parenteral Drugs Parenteral Drugs Major Product Offerings
7.12.4 BML Parenteral Drugs Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.12.5 BML Parenteral Drugs Key News
7.13 Pfizer (Hospira)
7.13.1 Pfizer (Hospira) Corporate Summary
7.13.2 Pfizer (Hospira) Parenteral Drugs Business Overview
7.13.3 Pfizer (Hospira) Parenteral Drugs Major Product Offerings
7.13.4 Pfizer (Hospira) Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Pfizer (Hospira) Key News
7.14 Pisa
7.14.1 Pisa Corporate Summary
7.14.2 Pisa Business Overview
7.14.3 Pisa Parenteral Drugs Major Product Offerings
7.14.4 Pisa Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Pisa Key News
7.15 Ozon Pharmaceuticals Ltd
7.15.1 Ozon Pharmaceuticals Ltd Corporate Summary
7.15.2 Ozon Pharmaceuticals Ltd Business Overview
7.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Major Product Offerings
7.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Ozon Pharmaceuticals Ltd Key News
7.16 Aspen Holdings
7.16.1 Aspen Holdings Corporate Summary
7.16.2 Aspen Holdings Business Overview
7.16.3 Aspen Holdings Parenteral Drugs Major Product Offerings
7.16.4 Aspen Holdings Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Aspen Holdings Key News
7.17 PSI Ltd
7.17.1 PSI Ltd Corporate Summary
7.17.2 PSI Ltd Business Overview
7.17.3 PSI Ltd Parenteral Drugs Major Product Offerings
7.17.4 PSI Ltd Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.17.5 PSI Ltd Key News
7.18 Wintac Limited
7.18.1 Wintac Limited Corporate Summary
7.18.2 Wintac Limited Business Overview
7.18.3 Wintac Limited Parenteral Drugs Major Product Offerings
7.18.4 Wintac Limited Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Wintac Limited Key News
7.19 AXA Parenterals Ltd
7.19.1 AXA Parenterals Ltd Corporate Summary
7.19.2 AXA Parenterals Ltd Business Overview
7.19.3 AXA Parenterals Ltd Parenteral Drugs Major Product Offerings
7.19.4 AXA Parenterals Ltd Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.19.5 AXA Parenterals Ltd Key News
7.20 Acebright
7.20.1 Acebright Corporate Summary
7.20.2 Acebright Business Overview
7.20.3 Acebright Parenteral Drugs Major Product Offerings
7.20.4 Acebright Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.20.5 Acebright Key News
7.21 Southwest Pharmaceutical
7.21.1 Southwest Pharmaceutical Corporate Summary
7.21.2 Southwest Pharmaceutical Business Overview
7.21.3 Southwest Pharmaceutical Parenteral Drugs Major Product Offerings
7.21.4 Southwest Pharmaceutical Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.21.5 Southwest Pharmaceutical Key News
7.22 Abbott
7.22.1 Abbott Corporate Summary
7.22.2 Abbott Business Overview
7.22.3 Abbott Parenteral Drugs Major Product Offerings
7.22.4 Abbott Parenteral Drugs Sales and Revenue in Global (2017-2022)
7.22.5 Abbott Key News
8 GLOBAL PARENTERAL DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Parenteral Drugs Production Capacity, 2017-2028
8.2 Parenteral Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Parenteral Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PARENTERAL DRUGS SUPPLY CHAIN ANALYSIS
10.1 Parenteral Drugs Industry Value Chain
10.2 Parenteral Drugs Upstream Market
10.3 Parenteral Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Parenteral Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Parenteral Drugs in Global Market
Table 2. Top Parenteral Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Parenteral Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Parenteral Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Parenteral Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Parenteral Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Parenteral Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Parenteral Drugs Product Type
Table 9. List of Global Tier 1 Parenteral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parenteral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Parenteral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Parenteral Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Parenteral Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Parenteral Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Parenteral Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Parenteral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Parenteral Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Parenteral Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Parenteral Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Parenteral Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Parenteral Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Parenteral Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Parenteral Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Parenteral Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Parenteral Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Parenteral Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Parenteral Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Parenteral Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Parenteral Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Parenteral Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Parenteral Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Parenteral Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Parenteral Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Parenteral Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Parenteral Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Parenteral Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Parenteral Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Parenteral Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Parenteral Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Parenteral Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Parenteral Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Parenteral Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Parenteral Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Parenteral Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Parenteral Drugs Sales, (K Units), 2023-2028
Table 46. Ostuka Pharmaceutical Corporate Summary
Table 47. Ostuka Pharmaceutical Parenteral Drugs Product Offerings
Table 48. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Teva Pharmaceutical Industries Corporate Summary
Table 50. Teva Pharmaceutical Industries Parenteral Drugs Product Offerings
Table 51. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Kelun Pharma Corporate Summary
Table 53. Kelun Pharma Parenteral Drugs Product Offerings
Table 54. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Cook Pharmica Corporate Summary
Table 56. Cook Pharmica Parenteral Drugs Product Offerings
Table 57. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Patheon Corporate Summary
Table 59. Patheon Parenteral Drugs Product Offerings
Table 60. Patheon Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. BAG Healthcare Corporate Summary
Table 62. BAG Healthcare Parenteral Drugs Product Offerings
Table 63. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Beximco Pharma Corporate Summary
Table 65. Beximco Pharma Parenteral Drugs Product Offerings
Table 66. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Baxter Healthcare Corporation Corporate Summary
Table 68. Baxter Healthcare Corporation Parenteral Drugs Product Offerings
Table 69. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. B. Braun Corporate Summary
Table 71. B. Braun Parenteral Drugs Product Offerings
Table 72. B. Braun Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Fresenius Corporate Summary
Table 74. Fresenius Parenteral Drugs Product Offerings
Table 75. Fresenius Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Albert David Corporate Summary
Table 77. Albert David Parenteral Drugs Product Offerings
Table 78. Albert David Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. BML Parenteral Drugs Corporate Summary
Table 80. BML Parenteral Drugs Parenteral Drugs Product Offerings
Table 81. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Pfizer (Hospira) Corporate Summary
Table 83. Pfizer (Hospira) Parenteral Drugs Product Offerings
Table 84. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Pisa Corporate Summary
Table 86. Pisa Parenteral Drugs Product Offerings
Table 87. Pisa Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Ozon Pharmaceuticals Ltd Corporate Summary
Table 89. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Offerings
Table 90. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Aspen Holdings Corporate Summary
Table 92. Aspen Holdings Parenteral Drugs Product Offerings
Table 93. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. PSI Ltd Corporate Summary
Table 95. PSI Ltd Parenteral Drugs Product Offerings
Table 96. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Wintac Limited Corporate Summary
Table 98. Wintac Limited Parenteral Drugs Product Offerings
Table 99. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. AXA Parenterals Ltd Corporate Summary
Table 101. AXA Parenterals Ltd Parenteral Drugs Product Offerings
Table 102. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Acebright Corporate Summary
Table 104. Acebright Parenteral Drugs Product Offerings
Table 105. Acebright Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Southwest Pharmaceutical Corporate Summary
Table 107. Southwest Pharmaceutical Parenteral Drugs Product Offerings
Table 108. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. Abbott Corporate Summary
Table 110. Abbott Parenteral Drugs Product Offerings
Table 111. Abbott Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 112. Parenteral Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 113. Global Parenteral Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 114. Global Parenteral Drugs Production by Region, 2017-2022 (K Units)
Table 115. Global Parenteral Drugs Production by Region, 2023-2028 (K Units)
Table 116. Parenteral Drugs Market Opportunities & Trends in Global Market
Table 117. Parenteral Drugs Market Drivers in Global Market
Table 118. Parenteral Drugs Market Restraints in Global Market
Table 119. Parenteral Drugs Raw Materials
Table 120. Parenteral Drugs Raw Materials Suppliers in Global Market
Table 121. Typical Parenteral Drugs Downstream
Table 122. Parenteral Drugs Downstream Clients in Global Market
Table 123. Parenteral Drugs Distributors and Sales Agents in Global Market
Table 1. Key Players of Parenteral Drugs in Global Market
Table 2. Top Parenteral Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Parenteral Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Parenteral Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Parenteral Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Parenteral Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Parenteral Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Parenteral Drugs Product Type
Table 9. List of Global Tier 1 Parenteral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parenteral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Parenteral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Parenteral Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Parenteral Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Parenteral Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Parenteral Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Parenteral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Parenteral Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Parenteral Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Parenteral Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Parenteral Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Parenteral Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Parenteral Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Parenteral Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Parenteral Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Parenteral Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Parenteral Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Parenteral Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Parenteral Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Parenteral Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Parenteral Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Parenteral Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Parenteral Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Parenteral Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Parenteral Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Parenteral Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Parenteral Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Parenteral Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Parenteral Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Parenteral Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Parenteral Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Parenteral Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Parenteral Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Parenteral Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Parenteral Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Parenteral Drugs Sales, (K Units), 2023-2028
Table 46. Ostuka Pharmaceutical Corporate Summary
Table 47. Ostuka Pharmaceutical Parenteral Drugs Product Offerings
Table 48. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Teva Pharmaceutical Industries Corporate Summary
Table 50. Teva Pharmaceutical Industries Parenteral Drugs Product Offerings
Table 51. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Kelun Pharma Corporate Summary
Table 53. Kelun Pharma Parenteral Drugs Product Offerings
Table 54. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Cook Pharmica Corporate Summary
Table 56. Cook Pharmica Parenteral Drugs Product Offerings
Table 57. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Patheon Corporate Summary
Table 59. Patheon Parenteral Drugs Product Offerings
Table 60. Patheon Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. BAG Healthcare Corporate Summary
Table 62. BAG Healthcare Parenteral Drugs Product Offerings
Table 63. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Beximco Pharma Corporate Summary
Table 65. Beximco Pharma Parenteral Drugs Product Offerings
Table 66. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Baxter Healthcare Corporation Corporate Summary
Table 68. Baxter Healthcare Corporation Parenteral Drugs Product Offerings
Table 69. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. B. Braun Corporate Summary
Table 71. B. Braun Parenteral Drugs Product Offerings
Table 72. B. Braun Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Fresenius Corporate Summary
Table 74. Fresenius Parenteral Drugs Product Offerings
Table 75. Fresenius Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Albert David Corporate Summary
Table 77. Albert David Parenteral Drugs Product Offerings
Table 78. Albert David Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. BML Parenteral Drugs Corporate Summary
Table 80. BML Parenteral Drugs Parenteral Drugs Product Offerings
Table 81. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Pfizer (Hospira) Corporate Summary
Table 83. Pfizer (Hospira) Parenteral Drugs Product Offerings
Table 84. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Pisa Corporate Summary
Table 86. Pisa Parenteral Drugs Product Offerings
Table 87. Pisa Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Ozon Pharmaceuticals Ltd Corporate Summary
Table 89. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Offerings
Table 90. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Aspen Holdings Corporate Summary
Table 92. Aspen Holdings Parenteral Drugs Product Offerings
Table 93. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. PSI Ltd Corporate Summary
Table 95. PSI Ltd Parenteral Drugs Product Offerings
Table 96. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Wintac Limited Corporate Summary
Table 98. Wintac Limited Parenteral Drugs Product Offerings
Table 99. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. AXA Parenterals Ltd Corporate Summary
Table 101. AXA Parenterals Ltd Parenteral Drugs Product Offerings
Table 102. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Acebright Corporate Summary
Table 104. Acebright Parenteral Drugs Product Offerings
Table 105. Acebright Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Southwest Pharmaceutical Corporate Summary
Table 107. Southwest Pharmaceutical Parenteral Drugs Product Offerings
Table 108. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. Abbott Corporate Summary
Table 110. Abbott Parenteral Drugs Product Offerings
Table 111. Abbott Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 112. Parenteral Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 113. Global Parenteral Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 114. Global Parenteral Drugs Production by Region, 2017-2022 (K Units)
Table 115. Global Parenteral Drugs Production by Region, 2023-2028 (K Units)
Table 116. Parenteral Drugs Market Opportunities & Trends in Global Market
Table 117. Parenteral Drugs Market Drivers in Global Market
Table 118. Parenteral Drugs Market Restraints in Global Market
Table 119. Parenteral Drugs Raw Materials
Table 120. Parenteral Drugs Raw Materials Suppliers in Global Market
Table 121. Typical Parenteral Drugs Downstream
Table 122. Parenteral Drugs Downstream Clients in Global Market
Table 123. Parenteral Drugs Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Parenteral Drugs Segment by Type
Figure 2. Parenteral Drugs Segment by Application
Figure 3. Global Parenteral Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Parenteral Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Parenteral Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Parenteral Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Parenteral Drugs Revenue in 2021
Figure 9. By Type - Global Parenteral Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Parenteral Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Parenteral Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Parenteral Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Parenteral Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Parenteral Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Parenteral Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Parenteral Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Parenteral Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Parenteral Drugs Sales Market Share, 2017-2028
Figure 19. US Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Parenteral Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Parenteral Drugs Sales Market Share, 2017-2028
Figure 24. Germany Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Parenteral Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Parenteral Drugs Sales Market Share, 2017-2028
Figure 33. China Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Parenteral Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Parenteral Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Parenteral Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Parenteral Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Parenteral Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Parenteral Drugs by Region, 2021 VS 2028
Figure 50. Parenteral Drugs Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Parenteral Drugs Segment by Type
Figure 2. Parenteral Drugs Segment by Application
Figure 3. Global Parenteral Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Parenteral Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Parenteral Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Parenteral Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Parenteral Drugs Revenue in 2021
Figure 9. By Type - Global Parenteral Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Parenteral Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Parenteral Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Parenteral Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Parenteral Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Parenteral Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Parenteral Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Parenteral Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Parenteral Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Parenteral Drugs Sales Market Share, 2017-2028
Figure 19. US Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Parenteral Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Parenteral Drugs Sales Market Share, 2017-2028
Figure 24. Germany Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Parenteral Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Parenteral Drugs Sales Market Share, 2017-2028
Figure 33. China Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Parenteral Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Parenteral Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Parenteral Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Parenteral Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Parenteral Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Parenteral Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Parenteral Drugs by Region, 2021 VS 2028
Figure 50. Parenteral Drugs Industry Value Chain
Figure 51. Marketing Channels
